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Reconstitution of membrane transportersThe aromatic acid:H+ symporter family of integral membrane proteins play an important role in the
microbial metabolism of aromatic compounds. Here, we show that the 4-hydroxybenzoate transporter
from Acinetobacter sp. ADP1, PcaK, can be successfully overexpressed in Escherichia coli and puriﬁed by
afﬁnity chromatography. Afﬁnity-puriﬁed PcaK is a stable, monodisperse homotrimer in the detergent
n-dodecyl-b-D-maltopyranoside supplemented with cholesteryl hemisuccinate. The puriﬁed protein
has a-helical secondary structure and can be reconstituted to a functional state in synthetic proteolipo-
somes. Asymmetric substrate transport was observed when proteoliposomes were energized by applying
an electrochemical proton gradient ðDlþHÞ or a membrane potential (DW) but not by DpH alone. PcaK was
selective in transporting 4-hydroxybenzoate and 3,4-dihydroxybenzoate over closely related compounds,
conﬁrming previous reports on substrate speciﬁcity. However, PcaK also showed an unexpected prefer-
ence for transporting 2-hydroxybenzoates. These results provide the basis for further detailed studies of
the structure and function of this family of transporters.
 2014 The Authors. Published by Elsevier Inc. This is anopenaccess article under theCCBY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).Introduction
The microbial metabolism of aromatic hydrocarbons is of broad
interest. This stems from the discovery of novel enzymes capable
of organic transformations, with potential in biotechnology and
bioprocessing [1], the drive to develop efﬁcient bioremediation
strategies in response to a variety of aromatic pollutants [2], the
desire to better appreciate microbial adaptation and diversity [3]
and the need to understand the breakdown and utilization of the
complex aromatic polymer lignin, which constitutes approxi-
mately 25% of the land-based biomass on Earth and is a key com-
ponent of the carbon cycle [4,5]. The benzene ring is one of the
most abundant chemical structures in the biosphere and aromatic
compounds are common microbial growth substrates [3].
The major facilitator superfamily of membrane transporters
includes a protein family that have been identiﬁed as speciﬁcAromatic Acid:H+ Symporters (AAHS)1 [6]. The AAHS transporters
are predicted to be composed of 450 amino acids arranged as a
bundle of 12 transmembrane a-helices, although very little experi-
mental evidence of protein structure is available. Members of the
AAHS family include transporters speciﬁc for 4-hydroxybenzoate
(4-HB) and 3,4-dihydroxybenzoate/protocatechuate (protein name
PcaK), 3-hydroxybenzoate (MhbT), 2,5-dihydroxybenzoate/gentisate
(GenK), benzoate (BenK) and 4-hydroxy-3-methoxybenzoate/vanil-
late (VanK). A BLAST search identiﬁes AAHS homologs across bacte-
rial phyla including the Proteobacteria, Actinobacteria, and Firmicutes
suggesting that the transport of aromatic acids is relatively common.
Current evidence for the transport activity and speciﬁcity of
AAHS transporters comes largely from studies of gain-of-function
in recombinant cell lines and loss-of-function in knockout cells
[7–14]. Among the best-studied of the AAHS family is PcaK. A
recombinant Escherichia coli cell line expressing PcaK from
Pseudomonas putida selectively transported protocatechuate and
4-HB with Vmax for 4-HB of 25 nmol/min/mg protein and KM of, circular
decyl-b-
enzoate;
y; PAGE,
tography
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electrochemical proton gradient independent of ATP [8,15]. A
pcaK strain of P. putidawas deﬁcient in 4-HB transport, and trans-
port by PcaK in rescued cell lines was abolished upon site-directed
mutagenesis of amino acid residues that are conserved within
AAHS and the wider superfamily [16,17].
Here, we establish methods for the recombinant expression and
puriﬁcation of PcaK that enable initial studies of structure and
function in vitro. We have chosen to study a PcaK homolog from
Acinetobacter, a genus of gammaproteobacteria that are ubiquitous
in the environment and which are relevant to human disease, bio-
technology and ecology. Our results provide some of the ﬁrst direct
evidence of the structure and function of this relatively uncharac-
terized membrane protein family.
Materials and methods
Materials
Isopropyl-b-D-thiogalactopyranoside (IPTG), Tris(2-carboxy-
ethyl)phosphine (TCEP), n-dodecyl-b-D-maltopyranoside (DDM)
and precast SDS–PAGE gels were from Generon. All aromatic acids,
L-arabinose, cholesteryl hemisuccinate Tris salt (CHS), 0.4–0.6 mm
acid-washed glass beads, valinomycin and Proteinase K-agarose
were from Sigma–Aldrich. HisTrap columns, PD-10 and PD
SpinTrap G-25 gel ﬁltration columns, Superdex 200 10/300 GL col-
umn, size exclusion column standards, and nitrocellulose mem-
brane were from GE Healthcare. Chemiluminescence reagents
(LumiGLO) were from Cell Signaling Technologies. E. coli strain
BL21-AI, LDS loading buffer, V5-HRP, pyranine and gels and
reagents for blue native PAGE were from Life Technologies.
Centrifugal concentrators were from Millipore. The detergent
compatible Lowry assay was purchased in kit format from Thermo-
Fisher. E. coli polar lipid extract and egg phosphatidylcholine were
from Avanti Polar Lipids.
Plasmid construct
cDNA encoding Acinetobacter sp. ADP1 PcaK (NCBI gene ID:
2879440) with a c-terminal V5 epitope (GKPIPNPLLGLDST) was
made as a synthetic gene (Euroﬁns MWG) ﬂanked by restriction
sites for NcoI and XhoI. This was cloned by cohesive end ligation
into the multiple cloning site of pET28a, in frame with a plas-
mid-borne His10 tag. The construct was veriﬁed by sequencing.
Protein expression
Recombinant PcaK was expressed in E. coli BL21-AI. For small-
scale expression cultures, a single colony from an agar plate was
used to inoculate 10 ml of LB media supplemented with 25 lg/ml
kanamycin. After overnight growth at 37 C with agitation at
220 rpm, 1 ml of this primary culture was used to inoculate
100 ml of the same media in a bafﬂed conical ﬂask and cultures
grown to OD600 of 0.7. Protein expression was induced by the addi-
tion of 1 mM IPTG and 0.1% (w/v) L-arabinose and growth contin-
ued for 2 h at 37 C, 220 rpm. Cells were harvested at 3300g,
resuspended in 0.5 ml of 50 mM sodium phosphate pH 7.4, 5 mM
EDTA, and transferred to a 1.5 ml eppendorf tube with an equiva-
lent volume of 0.4–0.6 mm glass beads. Cell lysates were prepared
by 5 cycles of 30 s vortex followed by a 30 s ice rest. A ﬁnal centri-
fugation at 13,000g for 1 min was used to pellet beads and unlysed
cells and the cell lysate was removed by pipetting. Total lysate pro-
tein concentration was determined with the detergent-compatible
Lowry assay. For protein puriﬁcation, the expression protocol was
scaled so that the primary culture was 100 ml and induction
cultures were a total volume of 6 l. Cells were harvested at 3300gand resuspended in 50–100 ml of 1 phosphate-buffered saline
with 5 mM TCEP.
Protein puriﬁcation
Harvested cells were lysed by one passage through a cell dis-
rupter (Constant Systems) at 25 KPSI. Unlysed cells and large deb-
ris were removed by centrifugation at 10,000g for 15 min. Cell
membranes were obtained from this lysate by ultracentrifugation
at 150,000g for 1 h at 4 C. The supernatant, corresponding to the
cytoplasmic fraction, was removed and pellets were resuspended
in 40 ml of 50 mM sodium phosphate pH 7.4, 150 mM NaCl, 5%
glycerol, 5 mM TCEP, 2% w/v DDM, 0.05% CHS when included.
Solubilization was carried out for 1 h at 4 C with constant mixing.
Insoluble membranes were pelleted at 150,000g, 1 h, 4 C. The
supernatant, corresponding to DDM-soluble membranes, was sup-
plemented with 20 mM imidazole and applied to an equilibrated
1 ml HisTrap column at a ﬂow rate of 1 ml/min via a peristaltic
pump. Unbound material ﬂowing through the resin was collected
for analysis. The column was washed with 40 volumes of Column
Buffer (50 mM sodium phosphate pH 7.4, 150 mM NaCl, 5% glyc-
erol, 5 mM TCEP, 0.05% w/v DDM, 0.01% CHS when included) with
75 mM imidazole before elution in 2.5 column volumes of Column
Buffer containing 0.5 M imidazole at a ﬂow rate of 0.15 ml/min.
The sample was immediately desalted into Column Buffer using a
PD-10 gel ﬁltration column and concentrated in a centrifugal con-
centrator with 100 kDa molecular weight cutoff. Protein concen-
tration was determined with the detergent-compatible Lowry
assay and, for puriﬁed protein, with absorbance at 280 nm using
a calculated extinction coefﬁcient of 76,890 M1 cm1 and a theo-
retical mass of 52.2 kDa (web.expasy.org/protparam/).
Protein analysis
For SDS–PAGE, samples were diluted into LDS loading buffer,
heated to 95 C for 10 min, and applied to a 12% Tris-Glycine gel.
For subsequent Western blotting, transfer to a nitrocellulose mem-
brane was performed in 12 mM Tris, 96 mM Glycine, 20%
Methanol, 0.01% SDS, pH 8.3. The nitrocellulose was blocked for
1 h in 1 PBS, 0.05% Tween-20 and 5% low-fat powdered milk.
The V5 antibody, directly conjugated to horseradish peroxidase,
was introduced at 1:10,000 dilution in the same buffer.
Membranes were washed ﬁve times in 1 PBS, 0.05% Tween-20
before incubation with commercial enhanced chemiluminescence
reagents and imaging on photographic ﬁlm. For direct immuno-
blots (‘‘dot blots’’) 2 ml of sample was added directly to nitrocellu-
lose membranes by pipetting and allowed to dry for 30 min before
blocking and developing as above.
Size exclusion chromatography was carried out on a Superdex
S200 10/300 GL column equilibrated in 1.5 column volumes of
Column Buffer and loaded with 2 ml of puriﬁed protein. The ﬂow
rate was 0.5 ml/min at 4 C and 1 ml fractions were collected.
Circular Dichroism was carried out on an Aviv instrument in a
2 mm path length cell at protein concentration of 1 mg/ml. The
approximate a-helical content was determined using Eq. (1)
[18,19]:
% a helix ¼ 100½ð½h222 þ 3000Þ=39;000 ð1Þ
Blue native PAGE was performed using a 4–16% gradient gel
according to the manufacturers instructions with 0.006%
Coomassie G-250 added to the sample before loading.
Multi-angle static light scattering coupled to size-exclusion
chromatography (SEC-MALS) was carried out essentially as
described [20]. The column was Superdex 200 10/300 GL loaded
with 95 ml of PcaK at 3 mg/ml and run at 0.8 ml/min. The buffer
was 50 mM sodium phosphate pH 7.4, 150 mM NaCl, 5% glycerol,
Fig. 1. Small-scale expression analysis of recombinant PcaK in Escherichia coli. SDS–
PAGE gels were Western blotted and probed with a V5 antibody directed toward an
artiﬁcial C-terminal V5 epitope.M, molecular weight marker in kDa as shown. 10 lg
total protein was loaded in each lane.
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Heleos II and Optilab rEX. The three-detector method in combina-
tion with the software package Astra 6.0.5 (Wyatt Technologies)
was used to calculate molecular masses [20]. A BSA standard was
used for calibration.
Reconstitution
To form liposomes, E. coli polar lipid mix and egg phosphatidyl-
choline were dissolved at 3:1 weight ratio in 1:1 chloroform:meth-
anol and allowed to dry. Mixed lipids were resuspended at a ﬁnal
lipid concentration of 40 mg/ml in 5 mM potassium phosphate pH
7.4, 0.25 M K2SO4. The lipid suspension was sonicated in a bath-
type sonicator for 15 min before undergoing 5 freeze/thaw cycles.
The sonication and freeze/thaw process was repeated. Liposomes
were prepared by extrusion to 0.4 mm diameter in a benchtop
extruder (Avanti Polar Lipids) at room temperature.
For reconstitution, 500 ml extruded liposomes at 40 mg/ml were
mixed with 45 ml of 20% (w/v) sodium cholate and 55 ml of puriﬁed
and size-exclusion polished PcaK at 1.6–2.0 mg/ml. After incuba-
tion at room temperature for 30 min with occasional gentle agita-
tion, cholate was removed with a PD SpinTrap G-25 column. The
recovered proteoliposomes were centrifuged at 200,000g for 1 h
and the supernatant removed. The liposome pellet was resus-
pended in 500 ml of 5 mM potassium phosphate pH 7.4, 0.25 M
K2SO4, 0.2 mM valinomycin, 1 mM pyranine and frozen. The same
protocol was followed for preparing lipid-only controls but DDM/
CHS buffer was used in place of protein.
For transport assays, proteoliposome or liposome samples were
thawed and diluted 4-fold into either 5 mM potassium phosphate
pH 7.4, 0.25 M K2SO4 (inﬂux) or 5 mM potassium phosphate pH
6.0, 0.25 M Na2SO4 and substrate (efﬂux). Samples were frozen,
thawed, and sonicated twice for 5 s with 15 s rest. The freeze/thaw
and sonication steps were repeated and external pyranine was
removed by gel ﬁltration.
Sucrose ﬂotation assays were carried out on a discontinuous
sucrose gradient. Samples in 60 % sucrose were layered with 4.5
volumes of 40% sucrose and 1 volume of buffer. Gradients were
centrifuged at 173,000g for 1 h and aliquots removed by pipetting
for dot blot analysis as above.
For protease digest assays, 5 mU of Proteinase K-agarose was
incubatedwith 100 ll undiluted proteoliposomes or equivalent vol-
ume of protein at 100 lg/ml. Proteolysis was stopped at speciﬁed
timepoints by pelleting Proteinase K-agarose for 10 s at 13,000g
and removing an aliquot of digested protein into SDS–PAGE loading
buffer. Samples were boiled before loading on SDS–PAGE.
Inﬂux assay
Substrate inﬂux was initiated by diluting 30 ml of pyranine-
loaded proteoliposomes (approximately 1 lg protein) with an
internal buffer of 5 mM potassium phosphate pH 7.4 and 0.25 M
K2SO4 into 3 ml of 5 mM potassium phosphate pH 6.0, 0.25 M
Na2SO4, 0.1 mM 4-hydroxybenzoate. Substrate was prepared
either as a 10 mM stock in acetonitrile or directly in the aqueous
buffer at low concentrations and allowed to dissolve completely
at room temperature for >1 h. The pH-dependent pyranine ﬂuores-
cence was measured with excitation at 460 nm and emission at
508 nm. Fluorescence was recorded over 5 min with 1 s sampling
intervals at 25 C. Nigericin was added at 1 lM to the assay buffer
as required.
Efﬂux assay
Substrate efﬂux was established by diluting 30 ml of pyranine-
loaded proteoliposomes with an internal buffer of 5 mM potassiumphosphate pH 6.0, 0.25 M Na2SO4, 0.1 mM substrate into 3 ml of
5 mM potassium phosphate pH 7.4, 0.25 M K2SO4. Pyranine ﬂuo-
rescence was followed as above.Results
Protein overexpression
The cDNA for Acinetobacter sp. ADP1 PcaK with a C-terminal V5
epitope and His10 tag (hereafter, PcaK) was cloned into the vector
pET28a for recombinant expression in E. coli. Fig. 1 shows the
results of a small-scale expression test. Induced cell lines carrying
PcaK showed a band upon Western blotting at 32 kDa. This is
substantially lower than the theoretical weight of the PcaK con-
struct of 52.2 kDa. It was previously shown that [35S]methionine-
labeled PcaK runs at a lower apparent molecular weight close to
30 kDa on SDS–PAGE gels [8]. Gel shifting has been observed
previously for integral membrane proteins and likely arises from
atypical SDS binding and conformational effects [21].
Recombinant protein puriﬁcation
PcaK was puriﬁed by immobilized metal afﬁnity chromatogra-
phy (IMAC) after solubilization in n-dodecyl-b-D-maltopyranoside
(DDM) with typical yields approximately 1 mg protein per litre
bacterial culture. Cell fractions were analysed by SDS–PAGE. Gel
staining with Coomassie brilliant blue (Fig. 2a) conﬁrmed the puri-
ﬁcation of a single major protein species at 32 kDa, with a minor
band at 70 kDa. The major band at 32 kDa was excised from the gel
and conﬁrmed as PcaK by peptide sequencing. Western blotting
against the V5 epitope was used to speciﬁcally track PcaK through
the puriﬁcation process and conﬁrmed that the band at 70 kDa was
immunopositive and could be assigned to a minor PcaK dimer
(Fig. 2b). Collectively, Fig. 2a and b shows that PcaK was targeted
to the E. coli plasma membrane upon expression, was successfully
solubilized in DDM and was efﬁciently bound to, and eluted from,
the IMAC resin.
Protein analysis
Size-exclusion chromatography is a ﬁnal polishing step in pro-
tein puriﬁcation that additionally provides information on protein
purity, monodispersity, and molecular size. When PcaK was puri-
ﬁed in DDM a substantial amount of the protein eluted in the col-
umn void and the chromatogram was highly heterogenous,
probably indicating non-speciﬁc protein aggregation (Fig. 3b).
Fig. 2. Puriﬁcation of PcaK. (a) Cell fractions and column puriﬁcation fractions were
loaded onto SDS–PAGE gels and stained with Coomassie. (b) Equivalent gel subject
to Western blotting with anti-V5. Puriﬁed PcaK migrated as two bands corre-
sponding to the apparent molecular weights of PcaK monomer (32 kDa) and dimer
(70 kDa). Fractions are: Whole cell, total cell lysate; Cytoplasm, supernatant after
ultracentrifugation; Membranes, pellet after ultracentrifugation; DDM-soluble,
membranes solubilized in detergent DDM, supernatant after ultracentrifugation;
Unbound, IMAC column ﬂow-through;Wash, column wash fraction; Elution, column
eluent. M, molecular weight marker in kDa as shown. lg protein, lg total protein
loaded per lane. BF, buffer front.
Fig. 3. Size-exclusion chromatography of puriﬁed PcaK. (a) In DDM/CHS mixed
micelles a single well-resolved peak is observed at an apparent molecular weight of
180 kDa relative to known protein standards as shown. Immunoblot of column
fractions (‘dot blot’) conﬁrms that the peak corresponds to PcaK. (b) In contrast,
chromatograms collected under conditions of DDM alone, without CHS added to
puriﬁcation buffers or the size exclusion buffer, show substantial heterogeneity.
Fig. 4. Blue native PAGE gel of PcaK after size exclusion chromatography. Total
weight of loaded protein in each lane is shown. When sufﬁcient protein is loaded a
single major band is observed at approximately 180 kDa, in agreement with size-
exclusion chromatograms. M, molecular weight marker in kDa.
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buffers substantially improved the performance of PcaK in column
chromatography (Fig. 3a). No protein was observed in the void vol-
ume in DDM/CHS samples, and a single well-resolved peak was
observed at an apparent molecular weight of 180 kDa. After a sin-
gle pass through the column, fractions underneath the peak were
pooled and reapplied to conﬁrm the peak position. Direct immuno-
blotting (‘dot blot’) of column fractions conﬁrmed that the peak
corresponded to V5-tagged PcaK. Size exclusion chromatography
thus conﬁrms that IMAC-puriﬁed PcaK in DDM/CHS is pure, mono-
disperse and stable with an apparent molecular weight of 180 kDa.
A non-denaturing blue native PAGE gel of PcaK recovered after
size exclusion chromatography is shown in Fig. 4. When <7 lg pro-
tein was loaded per lane a diffuse smear was observed. However,
loading P14 lg per lane resolved a single major band at approxi-
mately 180 kDa, in agreement with the apparent molecular weight
of the peak observed in size exclusion chromatography. Minorbands are observed at higher molecular weights, most obviously
at approximately 250 kDa, which presumably result from protein
aggregation in the native PAGE running buffer or differential
Coomassie binding.
The absolute molecular weight of the protein-detergent com-
plex was determined by multi-angle static light scattering coupled
to size-exclusion chromatography (SEC-MALS). The combined
results from simultaneous measurements of light scattering,
refractive index and absorbance at 280 nm (UV280) are shown in
Fig. 5. The protein-detergent complex was conﬁrmed to be mono-
disperse with Mw/Mn of 1.00 ± 0.01. The protein:detergent mass
ratio was 2:1 and the molecular mass of the total complex was
found to be 226 ± 2 kDa. Using the three-detector method [20]
the molecular mass for the protein component was found to be
Fig. 5. Molecular mass determination from size-exclusion chromatography with in-
line multi-angle static light scattering (SEC-MALS). Normalized outputs from
refractive index, light scattering and absorbance detectors are overlaid. Black lines
show the molecular mass calculations across the peak for the protein-detergent
complex (solid, 226 ± 2 kDa), protein component (dashed, 152 ± 2 kDa) and micelle
component (dotted, 74 ± 2 kDa).
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with literature values for DDM [22,23]. Since the PcaK monomer
has a theoretical mass of 52.2 kDa, these results are consistent with
the protein being a homotrimer in the protein-detergent complex.
These results illustrate the well-known difﬁculties in estimating
the oligomeric state of solubilized membrane proteins using
hydrodynamic methods such as native PAGE and SEC [20].
Sequence-based predictions of the secondary structure of PcaK
suggest that it will comprise 12 transmembrane a-helices similar
to many other members of the major facilitator superfamily [6].
Circular dichroism (CD) spectroscopy was used to assess the sec-
ondary structure content of puriﬁed PcaK (Fig. 6). A characteristic
a-helical spectrum was observed, with negative deﬂections in
ellipticity at 222 nm and 210 nm. As expected, the CD data show
no evidence for any extensive b-structure but allow for the pres-
ence of unstructured loops outside the membrane. The magnitude
of the 222 nm peak suggests that 45% of amino acids in PcaK will
be within a-helical segments (Eq. (1)). This is in reasonable agree-
ment with sequence-based predictions that approximately 252 of
483 amino acids (52%) will be within a-helices.Fig. 6. Circular dichroism spectrum of PcaK displaying a classical alpha-helical
signature.Reconstitution into proteoliposomes
PcaK was reconstituted into proteoliposomes by a cholate dilu-
tion method as described in Materials and Methods [24–26]. The
migration (‘ﬂotation’) of proteoliposomes on a discontinuous
sucrose gradient was used to determine the efﬁciency of reconstitu-
tion. Fig. 7 shows that upon reconstitution, almost all of the protein
becomes associated with proteoliposomes and ﬂoats to the top
of the gradient under centrifugation (Fig. 7, PL, fraction 1).
A protein only control (P) conﬁrms the retention of unreconstituted
protein at the bottom of the gradient.
A proteolytic digest assay was used to determine the orienta-
tion of reconstituted PcaK. Samples were incubated with
Proteinase K andWestern blotted to assess whether the C-terminal
V5 epitope had been degraded by the protease. PcaK in DDM/CHS
micelles was rapidly digested by Proteinase K, with signiﬁcant pro-
teolysis within the 10 s deadtime of the experiment (Fig. 8). The
band for full-length PcaK was substantially diminished and a par-
tial cleavage product was observed at approximately 20 kDa.
Reconstituted PcaK in proteoliposomes was equally susceptible
to proteolysis, suggesting that the C-terminal V5 tag is exposed
at the liposome exterior rather than being sequestered in the
lumen. Amino acid sequence analysis (http://topcons.cbr.su.se)
[27] predicts that PcaK will adopt Nin/Cin topology in vivo. PcaK is
thus apparently reconstituted in an ‘inside-out’ orientation,
whereby the side of the protein that faces the cell interior in vivo
faces the liposome exterior in vitro.
Substrate translocation assays
Substrate translocation was measured indirectly by ﬂuores-
cence of the pH-responsive ﬂuorescent dye pyranine [28–30].
The dye was efﬁciently incorporated into proteoliposomes by
freeze-thaw and sonication, evidenced by the visible ﬂuorescenceFig. 7. Sucrose ﬂotation assay demonstrating reconstitution of PcaK. Fractions were
removed from a discontinuous sucrose gradient as indicated and the presence of
PcaK determined by dot blot with anti-V5. Proteoliposomes (PL) migrate to the
buffer interface under ultracentrifugation while unreconstituted protein remains at
the bottom of the gradient, conﬁrmed by a protein-only control (P).
Fig. 8. Susceptibility of the C-terminal V5 tag to proteolysis as a measure of protein
orientation. Western blotting shows that Proteinase K immediately digests the C-
terminal V5 epitope of PcaK in detergent micelles (Protein) and after reconstitution
into proteoliposomes (PL), suggesting that the C-terminal of the reconstituted
protein is exposed at the proteoliposome exterior. Time in minutes.
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was initiated as described inMaterials and Methods by diluting pyr-
anine-loaded proteoliposomes and liposome controls into buffers
that establish either an inward-directed or outward-directed pro-
ton gradient ðDlþHÞ. Throughout, the assays were complicated by
high background signals arising from the spontaneous diffusion
of protons and aromatic acids across the membrane. All experi-
ments described here were carried out at <250 lM substrate to
minimize substrate diffusion. For unknown reasons, liposome sam-
ples consistently exhibited 1.3 higher ﬂuorescence than
proteoliposomes.
Fig. 9 shows the results of inﬂux assays under inward-directed
ðDlþHÞ (interior alkaline and negative) in the presence of 4-HB at
concentrations between 0 and 250 lM. Inﬂux is expected to cause
acidiﬁcation of the lumen, resulting in a decrease in pyranine ﬂuo-
rescence. Experiments in the absence of 4-HB showed a substantial
decrease in pyranine ﬂuorescence as a result of proton diffusion
across the membrane and subsequent acidiﬁcation of the lumen
(Fig. 9a and b). The relative rate and magnitude of this acidiﬁcation
was not altered by including 4-HB in the external buffer (Fig. 9a).
The KM of PcaK for 4-HB was previously determined to be 6 lM
[8]; thus the lowest concentration range used here is twice KM.
No differences were observed between proteoliposome samples
and liposome controls, and representative data from these experi-
ments at 100 lM 4-HB are shown in Fig. 9b. The introduction of the
proton ionophore nigericin immediately collapses the proton gra-
dient and abolishes the diffusion signal (Fig. 9b).
The data presented in Fig. 9 suggest that reconstituted PcaK is
not active as an inﬂux transporter. We thus investigated whether
we could establish substrate efﬂux in our reconstituted system.
For efﬂux assays, proteoliposomes were preloaded with 4-HB and
an outward-directed ðDlþHÞ (interior acidic and positive) was
applied. Efﬂux is expected to cause alkalization of the lumen and
a corresponding increase in pyranine ﬂuorescence.
Proteoliposomes showed a modest but reproducible increase in
the rate of alkalization over liposome controls (Fig. 10a),Fig. 9. Inﬂux assays under applied ðDlþHÞ (inside negative and alkaline). (a) Inﬂux
assays in proteoliposomes at different concentrations of 4-HB as shown. (b)
Comparison of data from proteoliposomes (PL) to control experiments in the
absence of protein (L). Traces are the mean of at least two replicates with error bars
omitted for clarity.demonstrating PcaK-catalysed efﬂux of substrate and H+ above
the rate of diffusion. Adjusting buffer conditions as described in
Materials and Methods allowed us to dissect the relative contribu-
tion of DpH and DW to transport. Fig. 10b and c suggest that
DW alone, but not DpH alone, is capable of driving substrate trans-
port in agreement with a previous report [8]. No evidence of sub-
strate efﬂux was observed in the absence of energetic gradients
(Fig. 10d).Substrate selectivity
Nichols and Harwood [8] used direct measurements of trans-
port activity, competition experiments and knock-out growth
studies to show that PcaK selectively transports 4-HB and protoc-
atechuate. A competition screen of a range of aromatic and non-
aromatic compounds suggested that 4-HB transport was partially
inhibited by competition with 3-hydroxybenzoate and certain hal-
ogenated benzoates but was not substantially inhibited by compe-
tition with, among others, 2-hydroxybenzoate/salicylate and
vanillate. Benzoate binds competitively to PcaK but is not trans-
ported. These results are of interest since benzoate and vanillate
are proposed to have their own transporters (BenK and VanK,
respectively) and so might not have overlapping speciﬁcity with
PcaK. We sought to test the substrate speciﬁcity of PcaK in our
reconstituted assay system, using the most closely related benzo-
ate compounds. Assays were carried out in the presence of DW
only to minimize any background signal from H+ diffusion. The
results are shown in Fig. 11.
Under the relatively permissive conditions of the assay (100 lM
each substrate) we observed no signiﬁcant difference between the
transport of 4-HB and protocatechuate. Relative to 4-HB, there was
a trend of reduced transport in the series protocatechute >
3-HB > vanillate > gentisate >> benzoic acid. Unexpectedly, there
was relatively higher transport of 2,4-dihydroxybenzoate (2,4-
DHB) and salicylate was found to be transported most effectively.Discussion
The genus Acinetobacter are ubiquitous gammaproteobacteria
that express at least the four AAHS transporters PcaK, BenK, VanK
and MucK enabling the mineralization of aromatic compounds via
the b-ketoadipate pathway [31–32]. The emergence of multidrug-
resistant strains of Acinetobacter has become a public health con-
cern [33–35]. Acinetobacter are also target organisms for bioreme-
diation [2] and industrial biotechnology [36] because of their
remarkable metabolic versatility. Understanding the structure
and function of archetypal AAHS transporter homologs from
Acinetobacter will help to illuminate a previously unstudied trans-
porter family and provide speciﬁc insight into the biochemistry of
a microorganism that is relevant to human disease, biotechnology
and ecology.
The data presented here show that Acinetobacter baylyi PcaK can
be recombinantly expressed, puriﬁed and reconstituted in vitro.
We found that the addition of the cholesterol derivative CHS to
puriﬁcation buffers was essential for stabilizing PcaK. This might
arise from speciﬁc sterol-protein interactions or from changes to
the shape, size or physicochemistry of the micelle. Light scattering
and small-angle X-ray scattering data [37] suggest that mixtures of
DDM and CHS form bicelle-like discoids that are larger than the
oblate ellipsoid micelles formed by DDM alone. This change in
micelle structure was proposed to arise largely from the interac-
tion of CHS with the detergent acyl chain region, allowing closer
packing and resulting in a thicker hydrophobic core and lower cur-
vature than a DDM micelle. These bicelle-like structures are likely
to be closer membrane mimics that can better accommodate the
Fig. 10. Substrate efﬂux (inside positive and acidic). Proteoliposomes, grey smoothed line on black error bars; liposome controls, black smoothed line on grey error bars.
Experiments were performed in the presence of (a) ðDlþHÞ, (b)DpH only, (c)DW only or (d) in the absence of any energetic gradient. All traces are mean ± range of at least two
replicates after subtracting relevant control experiments absent substrate.
Fig. 11. Substrate speciﬁcity of reconstituted PcaK under outward-directed DW.
Data are mean ± range of at least two independent experiments with different
protein and proteoliposome preparations, relative to a control absent substrate.
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speciﬁc protein sites, leading to increased stability and reduced
aggregation.
Transport assays presented here suggest that PcaK is
functionally asymmetric and prefers to transport 4-HB in a single
direction. In reconstituted proteoliposomes, only efﬂux is observed.
Because proteolysis assays suggest that PcaK reconstitutes in an
‘inside-out’ orientation, this corresponds to substrate import being
the dominant pathway in vivo. Previous competition assays in the
presence of 4-HB [8] suggested that PcaK transports protocatechu-
ate and, with lower efﬁciency, 3-HB, and that PcaK can bind to,
but not transport, benzoate. Of the numerous compounds tested
in the prior study, neither salicylate nor vanillate were found to
inhibit 4-HB uptake and so were not considered to be substrates
for PcaK. In contrast the data presented here suggest that under
the relatively high substrate concentrations required for our
in vitro assay, PcaK can transport a variety of aromatic acids with
hydroxyl substitutions at the 2-, 3- and 4-positions, with the
2- and 4-positions being favoured. The reduced transport of vanil-
late versus protocatechuate implies that hydroxyl substitutions
are generally favoured over methoxyl groups. Surprisingly,
C. Pernstich et al. / Protein Expression and Puriﬁcation 101 (2014) 68–75 75hydroxyl substitutions at the 2-position appeared to be an
important determinant for transport.
Considering these results, it is of note that a relatively narrow
substrate speciﬁcity appears to be a feature of the AAHS transport-
ers. P. putida MhbT was found to be selective for 3-HB over 2-HB
and 4-HB and is inhibited by, but does not transport, gentisate,
with almost no activity toward benzoate and protocatechuate
[7]. The relative growth rates of Acinetobacter strains in which benK
was disrupted suggested that BenK is speciﬁc in transporting ben-
zoate and benzaldehyde but not 4-HB, 2-aminobenzoate or benzyl
alcohol [38]. Where it has been determined, KM for AAHS trans-
porters is in the range 5–10 lM [7–9,13] consistent with relatively
selective substrate binding. We were prevented from studying
transport at concentrations closer to values of KM because of
decreased signal-to-noise at lower substrate concentrations. To
resolve the apparent discrepancy between our results in vitro and
cell-based competition assays it will be informative in the future
to determine the substrate binding afﬁnity of different aromatic
acids in vitro, for example by isothermal titration calorimetry,
and to make direct measurements of radiolabelled substrate trans-
port at low concentrations.
We thus present here an experimental platform for studying the
structure and function of PcaK in vitro. We anticipate that further
work based upon these results will characterize in full the molec-
ular basis for substrate transport and selectivity. The methods
described and validated here can potentially be extended for bio-
physical studies of other transporters within the AAHS family.
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